BackHemab Therapeutics Holdings Common Stock Overview

Hemab Therapeutics Holdings Common Stock EBIT

Hemab Therapeutics Holdings Common Stock ebit — quarterly history, peer benchmarks, and growth trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$23.61M

As of Mar 31, 2026

Annual EBIT (TTM)

N/A

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Hemab Therapeutics Holdings Common Stock (COAG) FAQ

Stockcircle tracks ebit for Hemab Therapeutics Holdings Common Stock (COAG), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This EBIT page is built for Hemab Therapeutics Holdings Common Stock's historical EBIT trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use EBIT as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main COAG overview so you can move from this figure to the surrounding analysis quickly.